Impact of discontinuing disease|modifying therapies on health care ...

Impact of discontinuing disease-modifying therapies on health care ...

This study revealed that DMT discontinuation was associated with higher health care services utilization among midlife patients with MS, ...

Impact of discontinuing disease-modifying therapies on health care ...

Impact of discontinuing disease-modifying therapies on health care utilization among midlife patients with multiple sclerosis in the United ...

File | qian-et-al-2024-impact-of-discontinuing-disease-modifying ...

qian-et-al-2024-impact-of-discontinuing-disease-modifying-therapies-on-health-care-utilization-among-midlife-patients.pdf Public.

Effects of disease-modifying treatments discontinuation in patients ...

Patients' most common reasons for leaving treatments and restarting them were exhaustion from the chronic therapeutic process and exacerbation of symptoms, ...

Impact of discontinuing disease-modifying therapies on health care ...

Conclusions: This study revealed that DMT discontinuation was associated with higher health care services utilization among midlife patients ...

Discontinuing disease-modifying multiple sclerosis therapies

despite similar relapse rates in those who continued and those who discontinued such treatment, the hazard of disability progression was increased for patients ...

Disease-Modifying Therapy Discontinuation in Multiple Sclerosis

One of greatest benefits would be reduction of DMT-associated adverse events, including risk of both minor and serious infections. Depending on the DMT, ...

Discontinuation of disease modifying therapies is associated with ...

After DMT discontinuation, 53 previously stable MS patients (32.9%) experienced disability worsening/progression (DWP). 29.2 and 40% of previously stable RRMS ...

Discontinuing Disease-Modifying Therapies in Multiple Sclerosis

As benefits of presently available DMTs wane with age, disease duration, and the change from a relapsing to progressive phenotype, side effects and risks ...

Discontinuation of disease-modifying therapies and health ...

Paper 3: During a 12-month follow-up, midlife patients who discontinued DMTs had higher rates of all-cause and non-MS-related inpatient hospitalization, as well ...

Discontinuation of MS Disease-Modifying Therapies Impacts ...

Disease-modifying therapy discontinuation in patients with MS is associated with a higher risk of developing disease activity.

Safety of Discontinuing Disease-modifying Therapy in Aging MS ...

While several studies have suggested stopping DMT may be safe in patients over 55 years old with at least two years without active relapses, ...

Comparing Stopping or Continuing Use of Disease Modifying ...

Disease modifying therapies, or DMTs, are medicines that help prevent or reduce relapses among patients with MS. But many older patients with MS don't have ...

A Decision Support Tool for the Discontinuation of Disease ...

A point-of-care decision support tool for discontinuing disease-modifying therapies in those with multiple sclerosis has the potential to reduce the risk ...

Study Shows Stopping Disease-Modifying Therapy May Be Safe for ...

The researchers concluded that discontinuation of DMTs in midlife patients with MS is associated with increased rates of healthcare resource ...

Discontinuation of first-line disease-modifying therapy in relapse ...

Mean age at the moment of DMT discontinuation was 45.3 years (SD 9.46), and the most frequent reason of DMT discontinuation was side effects of ...

Discontinuation of Disease-modifying Treatments in Relapsing ...

The most common reasons for discontinuing treatment were adverse events, lack of efficacy, and pregnancy, highlighting the importance of the risk/benefit ...

Discontinuing disease-modifying therapy in progressive multiple ...

The enormous associated costs are a burden to health services. Regular assessment is recommended to guide discontinuation of disease-modifying therapies when no ...

Impact of Medication Therapy Discontinuation on Mortality After ...

On average, patients who discontinued use of medications were older and did not complete high school. During 1-year follow-up, these patients ...

Disease-modifying therapies can be safely discontinued in an ...

The main predictors of post-discontinuation relapses were enhancing lesions on MRI within 3 years of discontinuation and lower disability (EDSS ...